VED-001

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameVED-001
Drug Alias NameELI001​ELI-001
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsVulvar NeoplasmsHead and Neck NeoplasmsCervical Intraepithelial Neoplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElicio Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElicio Therapeutics
Active IndicationsN/A
Inactive IndicationsVulvar NeoplasmsHead and Neck NeoplasmsCervical Intraepithelial Neoplasia

Other Information

ATC CodeN/A
Related LinksN/A